{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:18:27Z","timestamp":1772763507811,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.humimm.2022.08.002","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T19:48:00Z","timestamp":1659988080000},"page":"730-735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["HLA homozygosity is associated with Non-Hodgkin lymphoma"],"prefix":"10.1016","volume":"83","author":[{"given":"Christina L.","family":"Roark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bethany E.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael T.","family":"Aubrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheri","family":"Anobile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sapir","family":"Israeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu L.","family":"Phang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Braxton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea P.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian M.","family":"Freed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5408","key":"10.1016\/j.humimm.2022.08.002_b0005","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1126\/science.283.5408.1748","article-title":"HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage","volume":"283","author":"Carrington","year":"1999","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.humimm.2022.08.002_b0010","doi-asserted-by":"crossref","first-page":"12083","DOI":"10.1128\/JVI.77.22.12083-12087.2003","article-title":"Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection","volume":"77","author":"Thio","year":"2003","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.humimm.2022.08.002_b0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/ng0997-11","article-title":"Heterozygote advantage for HLA class-II type in hepatitis B virus infection","volume":"17","author":"Thursz","year":"1997","journal-title":"Nat. Genet."},{"issue":"23","key":"10.1016\/j.humimm.2022.08.002_b0020","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1182\/blood-2010-01-266775","article-title":"Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology","volume":"115","author":"Wang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2022.08.002_b0025","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1158\/0008-5472.CAN-17-2900","article-title":"HLA Class I and II Diversity contributes to the etiologic heterogeneity of Non-Hodgkin lymphoma subtypes","volume":"78","author":"Wang","year":"2018","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.humimm.2022.08.002_b0030","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1399-0039.1976.tb00570.x","article-title":"HLA haplotypes in a genetic isolate in Newfoundland. A population showing 8% homozygosity and a familial aggregate of lymphoma and immunodeficiency cases","volume":"8","author":"Larsen","year":"1976","journal-title":"Tissue. Antigens"},{"issue":"5","key":"10.1016\/j.humimm.2022.08.002_b0035","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1080\/10428190290021588","article-title":"Increased frequency of homozygosity for HLA class II loci in female patients with chronic lymphocytic leukemia","volume":"43","author":"Mueller","year":"2002","journal-title":"Leuk. Lymphoma"},{"issue":"6","key":"10.1016\/j.humimm.2022.08.002_b0040","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/leu.2011.30","article-title":"HLA homozygosity and haplotype bias among patients with chronic lymphocytic leukemia: implications for disease control by physiological immune surveillance","volume":"25","author":"Shah","year":"2011","journal-title":"Leukemia"},{"issue":"3-4","key":"10.1016\/j.humimm.2022.08.002_b0045","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/10428199409059592","article-title":"Human major histocompatibility complex contains several leukemia susceptibility genes","volume":"12","author":"Dorak","year":"1994","journal-title":"Leuk. Lymphoma"},{"issue":"5","key":"10.1016\/j.humimm.2022.08.002_b0050","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000154229","article-title":"Homozygous MHC genotypes and longevity","volume":"44","author":"Dorak","year":"1994","journal-title":"Hum. Hered"},{"key":"10.1016\/j.humimm.2022.08.002_b0055","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ajh.10365","article-title":"HLA system affects the age-at-onset in chronic myeloid leukemia","volume":"73","author":"Oguz","year":"2003","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.humimm.2022.08.002_b0060","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1182\/blood.V94.2.694","article-title":"Unravelling an HLA-DR association in childhood acute lymphoblastic leukemia","volume":"94","author":"Dorak","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2022.08.002_b0065","first-page":"875","article-title":"Nature of HLA-associated predisposition to childhood acute lymphoblastic leukemia","volume":"9","author":"Dorak","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.humimm.2022.08.002_b0070","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4274\/tjh.2016.0102","article-title":"The Frequency of HLA-A, HLA-B, and HLA-DRB1 Alleles in Patients with Acute Lymphoblastic Leukemia in the Turkish Population: A Case-Control Study","volume":"33","author":"Patiroglu","year":"2016","journal-title":"Turk. J. Haematol."},{"key":"10.1016\/j.humimm.2022.08.002_b0075","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1097\/QAD.0000000000000428","article-title":"Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study","volume":"28","author":"Gibson","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.humimm.2022.08.002_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(18)30360-6","article-title":"Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study","volume":"6","author":"Hernandez-Ramirez","year":"2019","journal-title":"Lancet. HIV"},{"key":"10.1016\/j.humimm.2022.08.002_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(20)30118-1","article-title":"Epidemiology of haematological malignancies in people living with HIV","volume":"7","author":"Kimani","year":"2020","journal-title":"Lancet. HIV"},{"key":"10.1016\/j.humimm.2022.08.002_b0090","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.humimm.2021.07.001","article-title":"HLA haplotype frequency estimation for heterogeneous populations using a graph-based imputation algorithm","volume":"82","author":"Israeli","year":"2021","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2022.08.002_b0095","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.humimm.2013.06.025","article-title":"Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry","volume":"74","author":"Gragert","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2022.08.002_b0100","unstructured":"R Core Team: R: A language and environment for statistical computing. Vienna, Austria, R Foundation for Statistical Computing, 2020."},{"key":"10.1016\/j.humimm.2022.08.002_b0105","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1182\/blood-2014-02-558767","article-title":"Fine-mapping of HLA associations with chronic lymphocytic leukemia in US populations","volume":"124","author":"Gragert","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2022.08.002_b0110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.leukres.2012.12.021","article-title":"Is immune escape via human leukocyte antigen expression clinically relevant in chronic lymphocytic leukemia? Focus on the controversies","volume":"37","author":"Guillaume","year":"2013","journal-title":"Leuk. Res."},{"key":"10.1016\/j.humimm.2022.08.002_b0115","doi-asserted-by":"crossref","first-page":"11260","DOI":"10.1073\/pnas.162006499","article-title":"MHC heterozygosity confers a selective advantage against multiple-strain infections","volume":"99","author":"Penn","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.humimm.2022.08.002_b0120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2013Part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet. Oncol"},{"key":"10.1016\/j.humimm.2022.08.002_b0125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/imr.12071","article-title":"Immunogenetics of HIV disease","volume":"254","author":"Martin","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.humimm.2022.08.002_b0130","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1470-2045(03)00983-5","article-title":"Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS","volume":"4","author":"Dal Maso","year":"2003","journal-title":"Lancet. Oncol."},{"key":"10.1016\/j.humimm.2022.08.002_b0135","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.285.13.1736","article-title":"Group AI-CMRS: Association of cancer with AIDS-related immunosuppression in adults","volume":"285","author":"Frisch","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.humimm.2022.08.002_b0140","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1073\/pnas.0711183105","article-title":"Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse","volume":"105","author":"Ohnishi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.humimm.2022.08.002_b0145","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/1040841X.2020.1760786","article-title":"Bacterial infection and non-Hodgkin's lymphoma","volume":"46","author":"Melenotte","year":"2020","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.humimm.2022.08.002_b0150","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1080\/10428194.2019.1617858","article-title":"The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population","volume":"60","author":"Zhong","year":"2019","journal-title":"Leuk. Lymphoma"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885922001513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885922001513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:56:49Z","timestamp":1759319809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885922001513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0198885922001513"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2022.08.002","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA homozygosity is associated with Non-Hodgkin lymphoma","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2022.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}